Effect of spironolactone on urinary protein excretion in patients with chronic kidney disease

Erkan Sengul1, Tayfun Sahin, Erce Sevin

  • 1Department of Nephrology, Faculty of Medicine, University of Kocaeli, Kocaeli, Turkey. dr.erkansengul@hotmail.com

Renal Failure
|December 25, 2009
PubMed

Insights

Spironolactone significantly reduced proteinuria in chronic kidney disease patients. This treatment may help slow kidney disease progression, but requires careful monitoring for hyperkalemia.

Area of Science:

  • Nephrology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) is a progressive condition often managed with renin-angiotensin system inhibitors.
  • Proteinuria is a key marker of CKD progression and cardiovascular risk.

Purpose of the Study:

  • To evaluate the antiproteinuric effect of spironolactone in CKD patients already treated with ACE inhibitors and/or ARBs.
  • To assess the impact of spironolactone on blood pressure and serum potassium levels.

Main Methods:

  • A study involving 33 CKD patients with proteinuria.
  • Spironolactone (25 mg/d) was added to existing ACE inhibitor/ARB therapy for eight weeks.
  • Urinary protein excretion and biochemical parameters were measured before and after treatment.

Main Results:

  • Spironolactone significantly decreased proteinuria by 47.9% (p < 0.001).
  • Significant reductions in systolic and diastolic blood pressure were observed.
  • Serum potassium levels increased significantly, indicating a risk of hyperkalemia.

Conclusions:

  • Spironolactone demonstrates a significant antiproteinuric effect in CKD patients on ACE inhibitors/ARBs.
  • This suggests spironolactone may be a valuable strategy for slowing CKD progression.
  • Close monitoring of serum potassium is crucial due to the risk of hyperkalemia.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...